Rapid molecular tests for tuberculosis and tuberculosis drug resistance: provider and recipient views

Nora Engel; Eleanor A Ochodo; Perpetua Wanjiku Karanja; Bey-Marrié Schmidt; Ricky Janssen; Karen Steingart; Sandy Oliver

doi:10.1002/14651858.cd014877

Rapid molecular tests for tuberculosis and tuberculosis drug resistance: provider and recipient views

Nora Engel, Eleanor A Ochodo, Perpetua Wanjiku Karanja, Bey-Marrié Schmidt, Ricky Janssen, Karen Steingart, Sandy Oliver

Clinical Sciences

Liverpool School of Tropical Medicine

Research output: Contribution to journal › Article › peer-review

8 Citations (Scopus)

Abstract

Objectives

This is a protocol for a Cochrane Review (qualitative). The objectives are as follows:

To synthesize end‐user and professional user perspectives and experiences with low‐complexity nucleic acid amplification tests (NAATs) for detection of tuberculosis and tuberculosis drug resistance.

Review question

What are the perspectives and experiences of people providing and receiving low‐complexity NAATs to diagnose tuberculosis and tuberculosis drug resistance?

Answering this question will allow us to identify the implications for effective implementation and health equity.

Original language	English
Article number	CD014877
Journal	Cochrane Database of Systematic Reviews
Volume	2021
Issue number	9
DOIs	https://doi.org/10.1002/14651858.cd014877
Publication status	Published - 3 Sept 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/14651858.cd014877

Engel et al-2021-Cochrane Database of Systematic ReviewsFinal published version, 197 KB

Cite this

@article{f5cbfb30d2624ff7b3ce6c44c343c374,

title = "Rapid molecular tests for tuberculosis and tuberculosis drug resistance: provider and recipient views",

abstract = "ObjectivesThis is a protocol for a Cochrane Review (qualitative). The objectives are as follows:To synthesize end‐user and professional user perspectives and experiences with low‐complexity nucleic acid amplification tests (NAATs) for detection of tuberculosis and tuberculosis drug resistance.Review questionWhat are the perspectives and experiences of people providing and receiving low‐complexity NAATs to diagnose tuberculosis and tuberculosis drug resistance?Answering this question will allow us to identify the implications for effective implementation and health equity.",

author = "Nora Engel and Ochodo, \{Eleanor A\} and Karanja, \{Perpetua Wanjiku\} and Bey-Marri{\'e} Schmidt and Ricky Janssen and Karen Steingart and Sandy Oliver",

year = "2021",

month = sep,

day = "3",

doi = "10.1002/14651858.cd014877",

language = "English",

volume = "2021",

journal = "Cochrane Database of Systematic Reviews",

issn = "1465-1858",

publisher = "John Wiley and Sons Ltd",

number = "9",

}

TY - JOUR

T1 - Rapid molecular tests for tuberculosis and tuberculosis drug resistance: provider and recipient views

AU - Engel, Nora

AU - Ochodo, Eleanor A

AU - Karanja, Perpetua Wanjiku

AU - Schmidt, Bey-Marrié

AU - Janssen, Ricky

AU - Steingart, Karen

AU - Oliver, Sandy

PY - 2021/9/3

Y1 - 2021/9/3

N2 - ObjectivesThis is a protocol for a Cochrane Review (qualitative). The objectives are as follows:To synthesize end‐user and professional user perspectives and experiences with low‐complexity nucleic acid amplification tests (NAATs) for detection of tuberculosis and tuberculosis drug resistance.Review questionWhat are the perspectives and experiences of people providing and receiving low‐complexity NAATs to diagnose tuberculosis and tuberculosis drug resistance?Answering this question will allow us to identify the implications for effective implementation and health equity.

AB - ObjectivesThis is a protocol for a Cochrane Review (qualitative). The objectives are as follows:To synthesize end‐user and professional user perspectives and experiences with low‐complexity nucleic acid amplification tests (NAATs) for detection of tuberculosis and tuberculosis drug resistance.Review questionWhat are the perspectives and experiences of people providing and receiving low‐complexity NAATs to diagnose tuberculosis and tuberculosis drug resistance?Answering this question will allow us to identify the implications for effective implementation and health equity.

U2 - 10.1002/14651858.cd014877

DO - 10.1002/14651858.cd014877

M3 - Article

SN - 1465-1858

VL - 2021

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 9

M1 - CD014877

ER -

Rapid molecular tests for tuberculosis and tuberculosis drug resistance: provider and recipient views

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this